What’s new in DF11 endpoints
Last updated
Was this helpful?
Last updated
Was this helpful?
There were no systemic changes in Data Freeze (DF) 11's endpoints, only minor updates.
New DF11 legacy samples, genotyped with the FinnGen array, were delivered from the following cohorts and biobanks:
~4700 The Finland-United States Investigation of NIDDM Genetics (FUSION) study subjects (, THL BB)
~3000 North Finland Birth Cohort study subjects born in 1986 (, Arctic BB)
~1900 North Finland Birth Cohort study subjects born in 1966 (, Arctic BB)
~1500 The diabetes register of the Vaasa hospital district study subjects (, Auria BB)
~500 Northern Finland aging individuals (, Arctic BB)
~650 Northern Finland aging individuals, (, Arcitic BB)
~550 Finnish Health in Teens study subjects (, THL BB)
~150 study subjects (THL BB)
~30 study subjects (THL BB)
No new legacy samples with previously generated genotypes from non-FinnGen arrays were delivered to FinnGen for DF11.
All changes in the endpoints are described in the changelog file .
1 endpoint (custom endpoint, created for userresults)
K11_K03_COMBINATION
6 new endpoints
DM2_NEPHROPATHY
DM2_RETINOPATHY
DM2_NEUROPATHY
DM1_NEPHROPATHY
DM1_RETINOPATHY
DM1_NEUROPATHY
336 modified endpoints
8 modified because typo in longname
10 endpoints with minor definition modifications
190 cancer control exclusions unified, now all EXALLC cancer endpoints have same exclusion rules
Comorbidity and diabetes complication endpoints have now omit=2 (these endpoints won’t be released to Sandbox, Pheweb or Risteys)
See for more details.